Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
68.78
-2.23 (-3.14%)
Jul 11, 2025, 2:29 PM - Market open

Novo Nordisk (NVO) Operating Income by Segment

History

Date Diabetes and Obesity Care Rare Disease
Mar 31, 2025 134.75B 536.00M
Dec 31, 2024 127.72B 620.00M
Sep 30, 2024 117.71B 661.00M
Jun 30, 2024 110.96B 504.00M
Mar 31, 2024 106.68B 2.74B
Dec 31, 2023 99.62B 2.95B
Sep 30, 2023 90.58B 2.32B
Jun 30, 2023 82.01B 4.15B
Mar 31, 2023 75.18B 5.49B
Dec 31, 2022 67.40B 7.41B
Sep 30, 2022 62.27B 9.09B
Jun 30, 2022 57.17B 9.26B
Mar 31, 2022 53.45B 9.36B
Dec 31, 2021 49.54B 9.11B
Sep 30, 2021 46.78B 9.41B
Jun 30, 2021 43.48B 10.27B
Mar 31, 2021 42.76B 10.05B
Dec 31, 2020 43.74B 10.38B
Sep 30, 2020 43.65B 11.17B
Jun 30, 2020 44.31B 10.63B
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.